Kisqali 400 MG daily dose 42S

Ended Awarded

Contract number
SPE2DR26FQN1Y
Awardee
Awarding agency
Obligated
$36,278

Award facts

Contract value 100% obligated
$36,277.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DLA) awarded a $36,277.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kisqali 400 mg daily dose tablets (42-count units) with performance in Conshohocken, Pennsylvania. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of October 21, 2025, one day after the award date of October 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain.

This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Kisqali, a cancer treatment medication, represents the type of specialty pharmaceutical product covered under this prime vendor agreement, which serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.

Quick answers

Who was awarded contract SPE2DR26FQN1Y?

SPE2DR26FQN1Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.

How much is contract SPE2DR26FQN1Y worth?

The government has obligated $36,278 on SPE2DR26FQN1Y.

Is contract SPE2DR26FQN1Y an order under another contract?

Yes. SPE2DR26FQN1Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.

Was contract SPE2DR26FQN1Y competed?

The extent of competition for SPE2DR26FQN1Y was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award